Breaking

Dymax to Demonstrate Light-Curing Technologies for Electronics Assembly at theAPEX EXPO 2026

Adhesives and equipment that address outgassing control, reliability, and performance requirements

Torrington, Connecticut – Dymax, a global manufacturer of light-curing materials and equipment, will exhibit at APEX EXPO 2026, held March 17–19, 2026, at the Anaheim Convention Center in Anaheim, California. Visitors can find Dymax in booth 3405, where the company will present UV/LED light-curable solutions developed for electronics assembly and printed circuit board manufacturing.

At the show, Dymax will conduct curing demonstrations focused on light-curable adhesives, coatings, and maskants used in electronics assembly to address common PCB-level challenges, including outgassing, component stability, and long-term reliability in demanding environments. A process demonstration using a Delta PVA 8 dispensing system will illustrate automated dispensing workflows used in printed circuit board assembly. Staking and bonding adhesives will be applied to glass substrates and encapsulants to flex circuits, then exposed to UV/LED light using a BlueWave® QX4 V2.0 LED curing unit to show how Dymax products achieve full polymerization in seconds as part of an integrated materials-and-equipment process.

The adhesives featured are specified for applications where performance under challenging conditions is critical. These include low outgassing requirements for space and LEO electronics and conformal coatings that provide excellent electrical insulation and protect assemblies from moisture, heat, and other environmental stresses. Additional solutions on display will include formulations intended for wearable electronics developed without IBOA and with reduced skin-sensitizing ingredients, as well as SpeedMask® maskants used to shield printed circuit boards prior to conformal coating and wave solder operations.

Throughout the exhibition, Dymax technical representatives will be available to discuss application requirements, material selection, and process considerations with attendees.

About Dymax

Dymax develops innovative rapid and light-curable materials, dispensing equipment, and UV/LED light-curing systems. The company’s adhesives, coatings, and equipment are perfectly matched to work seamlessly together, providing design engineers with tools to dramatically improve manufacturing efficiency. Major markets include aerospace and defense, medical device, electronics, automotive, and energy.

For additional information on Dymax, visit www.dymax.com or call 860-482-1010.

Joseph Wilson

Joseph Wilson is a veteran journalist with a keen interest in covering the dynamic worlds of technology, business, and entrepreneurship.

Recent Posts

Award-Winning Author, Marijke McCandless, Moderator for the San Diego Writers Festival

Marijke McCandless is an award-winning author, mindfulness coach, and playfulness instigator who helps others shed…

2 hours ago

New Insights Highlight Why Early Post-Surgical Healing Decisions Matter

New insights highlight the importance of early intervention, structured recovery protocols, and patient education after…

19 hours ago

TERRA Expands Global Certified Electronics Reuse & Recycling Network into Ecuador

Alliance now spans more than 120 certified facilities across 10 countries NASHVILLE, Tenn. — TERRA…

20 hours ago

Hudson Valley Wine & Food Festival Announces 48-Hour Ticket Presale with Early Bird Pricing

The Hudson Valley Wine & Food Festival has announced a 48-hour ticket presale offering early…

20 hours ago

Trim Gym Lawn Care Expands Across the Greater Toronto Area for Spring 2026 — Now Accepting New Residential Clients

Founded by North York entrepreneur Mike Davies, the well-established local company brings professional-grade equipment, reliable…

20 hours ago

Better quality of life despite ureteral stents: New technology offers potential to reduce pain, infections, and emergency treatments for more than 5,500 patients daily

Baiersdorf, Germany -UroNova GmbH today announced the results from its CLEANUS clinical study. The data…

20 hours ago

This website uses cookies.